‘Our proprietary lead substance, Stomach-007, has previously been evaluated for a different indication in individual clinical trials and been shown to be secure and well tolerated,’ said company CEO, Michael D. Pierschbacher, PhD. ‘Our objective is to conduct scientific trials on Stomach-007 to confirm as quickly as possible the noticed preclinical efficacy for treatment of Advertisement.’ Related StoriesCollaborative approach may speed discovery of fresh preventive remedies for Alzheimer's diseaseEight myths and truths about Alzheimer's diseaseNew technique helps study protein changes in brain tissue of Alzheimer's patientsALSP was recently awarded a National Institute on Ageing contract to cover all Investigational New Medication -enabling toxicology and pharmacology research.Projected savings derive from raising participation in UnitedHealthcare’s coverage options beneath the Administaff Group Health Plan. The dental plan shall see a modest premium increase for 2011, and a cap shall connect with any potential increases for 2012 and 2013. We are very pleased with the terms of our new contract with UnitedHealthcare, said Richard G. Rawson, Administaff’s president. We believe this fresh set up demonstrates the long-term achievement of our romantic relationship, and we enjoy UnitedHealthcare’s ongoing commitment to helping us provide premium health care benefits for worksite workers at America’s best small and medium-sized businesses.